MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Deep learning approach for Parkinson’s disease classification from facial expressions: A pilot feasibility study

O. Phokaewvarangkul, P. Vateekul, D. Surangsrirat, R. Bhidayasiri (Bangkok, Thailand)

Meeting: MDS Virtual Congress 2020

Abstract Number: 1423

Keywords: Blink rate, Experimental therapeutics, Parkinsonism

Category: Technology

Objective: To apply deep learning and traditional machine learning approaches to images of different facial expressions from patients and controls to aid in the prediction of PD.

Background: Impaired facial expressions are a common symptom of Parkinson’s disease and may provide valuable clues for early diagnosis. The recent advancements in computation techniques and processing units together with the availability of larger datasets enable the possibility of using artificial intelligence (AI) techniques, especially a deep learning approach, for computer vision tasks in medical diagnosis.

Method: Four classification models were applied to evaluate the facial images; two traditional machine learning techniques: k-Nearest Neighbour (kNN) and Support Vector Machine (SVM) and two modern deep learning techniques: ResNet50 and EfficientNet. The images were collected using ChulaPD mobile application. Participants were asked to perform eight different facial expressions; neutral, joy, sadness, anger, fear, surprise, disgust, and contempt. The images were sent to the cloud-based storage for data analysis.

Results: The image augmentation techniques were applied to 1,016 images, 384 images from PD and 632 from HC, to artificially expand the size of the training dataset. Three-fold cross-validation was performed to address the overfitting or selection bias. Single and combined expressions were evaluated according to the aforementioned models. The ‘Joy’ expression with EfficientNet was the best to differentiate between PD and HC; Accuracy = 0.7083 and Sensitivity= 0.6667. ResNet50 had the best result with ‘Surprise’ expression; Accuracy = 0.7333 and Sensitivity= 0.6300. The best result from traditional models was from SVM with ‘Fear’ expression; Accuracy = 0.6800 and Sensitivity = 0.2567.In our experiments, deep learning techniques consistently outperformed traditional machine learning techniques.

Conclusion: Diminished facial expressions are one of the common indicators of PD, facial recognition using a deep learning technique could play a role in an improvement of the detection and diagnosis of an early-stage PD. This pilot study offers a simple, non-invasive, AI-assisted tool to differentiate the facial expressions of PD patients from healthy control, with the potential to be a promising future tool for screening a large number of high-risk PD population.

IMG 4701

To cite this abstract in AMA style:

O. Phokaewvarangkul, P. Vateekul, D. Surangsrirat, R. Bhidayasiri. Deep learning approach for Parkinson’s disease classification from facial expressions: A pilot feasibility study [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/deep-learning-approach-for-parkinsons-disease-classification-from-facial-expressions-a-pilot-feasibility-study/. Accessed June 19, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/deep-learning-approach-for-parkinsons-disease-classification-from-facial-expressions-a-pilot-feasibility-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #23660 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley